Product Name :
Alizarin
CAS No.:
72-48-0
Purity :
> 99%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
OC1=C(O)C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O
Product Description :
Alizarin strongly inhibits P450 isoform CYP1A1, CYP1A2 and CYP1B1 with IC50 of 6.2 μM, 10.0 μM and 2.7 μM, respectively weakly inhibits CYP2A6 and CYP2E1, and does not inhibit CYP2C19, CYP3A4 and CYP3A5.
Formula:
C14H8O4
Molecular Weight :
240.{{Okadaic acid} medchemexpress|{Okadaic acid} Apoptosis|{Okadaic acid} Biological Activity|{Okadaic acid} Description|{Okadaic acid} manufacturer|{Okadaic acid} Autophagy} 21
Synonyms:
Anthraquinonic
Additional Information:
|CAS No. 72-48-0 ; |Synonyms Anthraquinonic ; |Formula C14H8O4 ; |Molecular Weight 240.{{Emixustat} medchemexpress|{Emixustat} Protocol|{Emixustat} Formula|{Emixustat} manufacturer|{Emixustat} Epigenetic Reader Domain} 21 ; |SMILES OC1=C(O)C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O ; |Target CYP2C19, CYP3A4 and CYP3A5.PMID:24275718 ; |Product Description Alizarin strongly inhibits P450 isoform CYP1A1, CYP1A2 and CYP1B1 with IC50 of 6.2 μM, 10.0 μM and 2.7 μM, respectively weakly inhibits CYP2A6 and CYP2E1, and does not inhibit CYP2C19, CYP3A4 and CYP3A5. ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO